Oct 24 (Reuters) - Boule Diagnostics AB BOUL.ST:
Q3 NET SALES AMOUNTED TO SEK 127.2 MILLION (130.4)
Q3 ADJUSTED OPERATING PROFIT AMOUNTED TO SEK 12.0 MILLION (15.3), CORRESPONDING TO AN ADJUSTED OPERATING MARGIN OF 9.4 % (11.8)
WE ARE STARTING TO SEE EARLY SIGNS OF STABILISATION, WITH SLIGHTLY MORE BALANCED PRICING OF INSTRUMENTS AND IMPROVED DEMAND IN OUR KEY MARKETS AS GOVERNMENT TENDER PROCESSES RESUMES
Source text: ID:nMFN3ZQ1PY
Further company coverage: BOUL.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))